Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Solid Biosciences has raised $240.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in March 2026.
Solid Biosciences's investors include RA Capital Management, Cormorant Asset Management, Perceptive Advisors, Foresite Capital, Janus Henderson Investors.
Solid Biosciences is headquartered in Charlestown, United States.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Solid Biosciences is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Solid Biosciences — Funding & Investors." VCBacked, March 6, 2026, https://www.vcbacked.co/company/solid-biosciences. Accessed August 23, 2026.
VCBacked. (2026). Solid Biosciences — Funding & Investors. Retrieved August 23, 2026, from https://www.vcbacked.co/company/solid-biosciences
{{cite web |title=Solid Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/solid-biosciences |website=VCBacked |access-date=August 23, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated